Advertisement
Singapore markets close in 2 hours 34 minutes

  • Straits Times Index

    3,297.56
    -16.49 (-0.50%)
     

  • Nikkei

    38,946.93
    -122.75 (-0.31%)
     

  • Hang Seng

    19,228.06
    -408.16 (-2.08%)
     

  • FTSE 100

    8,424.20
    +3.94 (+0.05%)
     

  • Bitcoin USD

    71,151.45
    +4,142.12 (+6.18%)
     

  • CMC Crypto 200

    1,529.18
    +40.64 (+2.73%)
     

  • S&P 500

    5,308.13
    +4.86 (+0.09%)
     

  • Dow

    39,806.77
    -196.82 (-0.49%)
     

  • Nasdaq

    16,794.88
    +108.91 (+0.65%)
     

  • Gold

    2,419.40
    -19.10 (-0.78%)
     

  • Crude Oil

    79.22
    -0.58 (-0.73%)
     

  • 10-Yr Bond

    4.4370
    +0.0170 (+0.38%)
     

  • FTSE Bursa Malaysia

    1,624.47
    -3.03 (-0.19%)
     

  • Jakarta Composite Index

    7,227.92
    -38.77 (-0.53%)
     

  • PSE Index

    6,623.51
    -59.27 (-0.89%)
     

Inspire Medical Systems, Inc. to Report First Quarter 2024 Financial Results on May 7, 2024

Inspire Medical Systems
·1-min read
Inspire Medical Systems
Inspire Medical Systems

MINNEAPOLIS, April 02, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the first quarter 2024 after the close of trading on Tuesday, May 7. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.

A webcast of the call will be accessible via the Investor Relations page of the Inspire website or through this link: Inspire's Q1 2024 earnings call webcast. For those not planning to ask a question of management, the Company recommends listening via the webcast.

If you plan to ask a question, please use the following link: Inspire's Q1 2024 earnings call. After registering, an email will be sent, including dial-in details and a unique conference call access code required to join the live call. To ensure you are connected prior to the beginning of the call, the Company suggests registering a minimum of 10 minutes before the start of the call.

ADVERTISEMENT

Following the call, a replay will be available on the Company's Investor Relations website approximately two hours after the event and archived on the site for two weeks.

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443